Drug Type Cytokines |
Synonyms G0 C15, G0-C15, GO-C-15 |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bladder Cancer | Preclinical | United States | 01 Nov 2021 | |
| Breast Cancer | Preclinical | United States | 01 Nov 2021 | |
| Colorectal Cancer | Preclinical | United States | 01 Nov 2021 | |
| Head and Neck Neoplasms | Preclinical | United States | 01 Nov 2021 | |
| Lung Cancer | Preclinical | United States | 01 Nov 2021 | |
| Prostatic Cancer | Preclinical | United States | 01 Nov 2021 | |
| Squamous Cell Neoplasms | Preclinical | United States | 01 Nov 2021 |






